Novartis Canada extends Health Equity Initiative effort, fueling innovation and impact for second year Français
MONTREAL, May 14, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is pleased to announce the launch of the second edition Health Equity Initiative. Aimed at promoting equitable healthcare for Canadians by addressing health disparities, Novartis Canada will award $500,000 to non-profit projects focused on improving health equity and addressing the unique healthcare challenges faced by underserved and marginalized populations.
According to the World Health Organization, health equity is achieved when everyone can attain their full potential for health and well-being. i However, despite having a universal healthcare system, Canada ranks third to last with respect to equity in healthcare access and experience among nine peer countries, highlighting persistent challenges faced by underserved communities. ii
The 2025 Health Equity Initiative aims to address Canada's existing healthcare access inequity by supporting individuals and organizations that are fully immersed in their communities, understand their unique needs, and are dedicated to advancing fair access to healthcare. By empowering these agents of change, Novartis seeks to inspire broader community engagement and action to improve healthcare outcomes.
Sustaining the momentum from the inaugural Health Equity Initiative in 2024, Novartis will be awarding additional grants to support Canadian non-profit and/or charitable organizations that are pioneering innovative solutions towards equitable healthcare.
"We are incredibly proud to continue our commitment to supporting health equity in Canada by launching the second year of this Initiative," said Mark Vineis, Country President, Novartis Canada. "All Canadians deserve equitable access to healthcare and Novartis believes in the power of supporting sustainable, grassroots projects that help advance health equity for underserved communities."
In total, more than 130 applications for funding were received in the Initiative's first year. The 2024 winners were selected through a thorough evaluation process designed in collaboration with Equity Mobilizing Partnerships in Community (EMPaCT), each exemplifying the spirit and impact of the Initiative through their innovative approaches to addressing and improving health equity:
Black Physicians of Canada: By creating a national database of Black physicians across Canada, this project is to tackling health disparities and improving access to culturally sensitive care, ensuring that Black patients receive health services that acknowledge and respect their unique needs. The development of a Black health digital hub further enhances connectivity and resource sharing among healthcare providers and patients.
Foundations for Social Change: This project addresses the health equity challenges faced by those transitioning out of homelessness and extreme poverty in Vancouver by implementing a comprehensive support system – including mental health services, healthcare navigation support and direct cash transfers – to empower individuals with the tools and resources needed to improve health outcomes.
Fort Severn First Nation: The northernmost community in Ontario, this project focuses on bridging the healthcare access gap for First Nations communities. By establishing a team of community health coordinators known as Payukotayno Meno ya win, the initiative ensures timely diagnosis and treatment, as well as access to preventative care. These efforts promote greater engagement between families and the healthcare system, fostering trust and improving overall health outcomes within the community.
"The Health Equity Initiative's 2024 winners have set a powerful precedent, showcasing the impact of a community-based focus on innovation and collaboration," says Vineis. "Novartis Canada recognizes the importance of supporting community organizations and is committed to supporting all future winners in their missions to drive meaningful action."
How to apply for funding
Canadian non-profit and/charitable organizations that are passionate about advancing health equity and committed to creating a more inclusive healthcare system are encouraged to learn more and apply for funding by visiting www.novartis.com/ca-en/esg/health-equity-initiative.
The deadline for applications is 11:59 p.m. PT on June 16, 2025
About Novartis
Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 600 people to serve the evolving needs of patients and the healthcare system and invests over $30 million in R&D yearly in the country. For more information visit www.novartis.ca.
SOURCE Novartis Pharmaceuticals Canada Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
Ambassadors Accelerate CarePatrol's AlignedCare™ Program
Beta testing begins for proprietary value-based care model driven by advisor insights OTTAWA, Ontario, June 9, 2025 /CNW/ -- CarePatrol, a leading senior care solutions franchise with more than 200 locations open across 40 states and Canada, is advancing its proprietary AlignedCare™ Value-Based Care (VBC) Certification Program with the selection of its first Ambassador team. The select group of experienced advisors will act as early adopters, leading beta testing and shaping the future for value-based care integration within senior care advisory services. The AlignedCare Program represents a transformative step in how care solutions are guided and recommended. Advisors who complete the certification will be qualified to support families using an evidence-informed model based on outcomes, social determinants of health, and care collaboration. Built on value-based care principles informed by the 8 Dimensions of Wellness, the program enables higher levels of client precision and personalization, while also expanding value-based care partnership networks. Throughout the beta phase, AlignedCare Ambassadors will be applying the model within their current practices and providing critical feedback on assessment tools, strategic workflows, and outcomes tracking. Insights provided and gained during this phase will assist in system-wide implementation. "We're thrilled with the early momentum of the AlignedCare Program and the enthusiasm from our Ambassador team," said Becky Bongiovanni, co-founder and brand president of CarePatrol. "Our advisors are stepping into a leadership role that goes far beyond traditional care advisory. By aligning every recommendation with value-based care principles, we are building a more complete, measurable, and compassionate model for senior care." Each AlignedCare Ambassador plays a vital role in strengthening CarePatrol's mission to strengthen senior care advisory services through professional development, collaboration, and meaningful community impact. This next phase of the initiative builds on CarePatrol's legacy of innovation, using evidence-informed practices to deliver personalized, outcome-focused advisory solutions. A full system-wide rollout of the AlignedCare™ Certification Program is anticipated later this year. About CarePatrol CarePatrol is the nation's largest senior care solutions franchise in the United States. With more than 225 locations sold across 40 states and Canada, local senior advisors provide a no-cost service in helping families find quality, top-rated independent living, assisted living, memory care, long-term care, and home care. Founded in 1993, CarePatrol began franchising in 2009 and is now part of the Best Life Brands family, with private equity backing by The Riverside Company. CarePatrol is proud to have earned the Franchisee Satisfaction Award from Franchise Business Review for 14 years in a row, including its induction into the Hall of Fame in 2024, and has earned placement on the Entrepreneur Franchise 500 list. For more information, visit
Cision Canada
4 hours ago
- Cision Canada
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care Français
TORONTO, June 9, 2025 /CNW/ - Sanofi Canada today announced the appointment of James Guy as Country Lead, Canada and General Manager, Specialty Care. In this role, Guy will lead Sanofi's Canada Country Council, which manages the operations of the company's three business units and functions. Guy will also head the Specialty Care business unit in Canada. Country Lead, Canada and General Manager, Specialty Care "This is an exciting time in Sanofi's history, with the potential for our promising pipeline to deliver several scientific breakthroughs that can improve healthcare around the globe. The company is building on this momentum, leveraging next-gen technology and AI, to turn breakthrough science into reality for patients. I feel privileged to be back home in Canada working with our talented teams; I'm confident that their patient-focused approach will deliver new solutions that will continue to benefit Canadian patients." Guy brings over two decades of pharmaceutical industry experience, including 13 years with Sanofi in global, US, and Canadian leadership roles, most recently as the Immunology Franchise Head in Canada. His prior positions within Sanofi include International Strategic Marketing Director based in the Czech Republic, Respiratory Global Brand Lead based in the US, and Regional Business Director in the US affiliate. A Canadian citizen, Guy holds a in Applied Chemistry & Biology from Toronto Metropolitan University, an in Biomedical Sciences from the University of Bradford (UK), and an MBA from Rutgers University (USA). With over 2,000 employees across the country, Sanofi's operations in Canada include R&D, Commercial, the country's largest biomanufacturing facility, and an AI Centre of Excellence. The company is uniquely positioned to deliver across the full life sciences value chain within Canada. As Country Lead, Guy will chair the Canada Country Council, which includes: About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. In Canada, we employ over 2,000 people and invest 20% of our revenue annually in biopharma research, representing $1.2 billion CAD in R&D over the last decade, creating jobs, business, and opportunity throughout the country. We are the largest biomanufacturing facility in Canada and are on track to deliver over $2 billion in new infrastructure investments by 2028, including two new vaccine manufacturing facilities at our Toronto Campus. For more than 110 years, we have been working in collaborative partnerships with a vast network of healthcare stakeholders and are committed to creating a healthier future in Canada.
Cision Canada
6 hours ago
- Cision Canada
Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces Français
An estimated 25% of Canadian employees report living with migraine, yet only 12% receive a diagnosis from healthcare professionals i Limited education and employee resources continues to result in stigma related to migraine in the workplace, significantly impacting employee performance and well-being ii KIRKLAND, QC, June 9, 2025 /CNW/ - Pfizer Canada, in partnership with Migraine Canada and Migraine Quebec, is reintroducing the Out of Office for Migraine Awareness campaign for Migraine Awareness Month in June. In its second year, the campaign continues to raise awareness of the impact of migraine and empower Canadians to foster more supportive work environments for those living this debilitating neurological condition that deeply impacts professional and personal life. iii During Migraine Awareness Month, Canadian organizations, employers, and employees are encouraged to use their Out of Office (OOO) Alert for four hours – the minimum duration of an average migraine – to show solidarity with colleagues living with migraine (example below). iv,v "Migraine is widely misunderstood in the workplace and ultimately leads employees to 'push through,' despite it reducing productivity and potentially leading to burnout," says Debby Carreau, CEO and Founder, inspiredHR, a HR consultancy firm. "By understanding what migraine is, colleagues can support those living with the condition by reducing the stigma associated with taking time off work due to migraine attacks." Migraine prevalence peaks during prime working years, and statistics suggest that a substantial portion of the workforce is affected by it. vi Migraine management resources equip organizations to help their employees better understand absenteeism and presenteeism (i.e. when employees are not fully functioning in the workplace because of an illness). i "Migraine can be physically and mentally debilitating for millions of Canadians, often going unnoticed by peers," says Wendy Gerhart, Executive Director, Migraine Canada. "The OOO Alert is a simple step that colleagues can share to show compassion and ignite more meaningful dialogue around migraine in the workplace. We encourage Canadians to tap into available resources, replacing stigma and skepticism with support." About Migraine in the Workplace More than five million Canadians live with migraine. ii While migraine affects all demographics, its prevalence peaks for people in their 30s and 40s, when most individuals are likely employed. vi Despite this, migraine remains highly misunderstood and stigmatized in the workplace as being directly related to one's ability to work. vii "The implication of migraine costs the Canadian economy many billions of dollars each year ii with costs related to missed workdays alone being at 980 million dollars per year," ii ,viii says Dr. Will Kingston, Neurologist, Sunnybrook Hospital, Toronto. "Despite this, migraine remains underdiagnosed due to a lack of education and training on where to access resources for support, leading to profound impact on work performance and wellbeing." ii "At Pfizer Canada we're committed to supporting migraine patients as well as educating our communities," said Ranjita Banerjee, Primary Care Portfolio Lead, Pfizer Canada."Leveraging an OOO Alert is the perfect conversation starter, at the office or virtually, to help colleagues better support one another. We're excited to see how this campaign evolves in its second year to spread the word about migraine." As pictured below, the OOO Alert message can provide key migraine information, statistics, and resources to show allyship for colleagues impacted by migraine while encouraging their professional network to learn more. Additional Quotes "Migraine can be trivialized both in professional environments and in day-to-day life. We work hard to provide resources to those who experience it, as well as those in their personal and professional circles, so they can gain a deeper knowledge of the condition, its possible treatments, and the potential accommodations that can help sustain employment amidst the challenges," says Véronique Clément, Executive Director, Migraine Québec. "This campaign, and the small step of turning on an OOO Alert, is a great opportunity for employers in particular to support their colleagues who may feel limited and isolated in the workplace." "Migraine is a chronic disease ix without a definitive cure, yet with proper management especially in the workplace, the impact can be significantly reduced," said Dr. Heather Pim, associate clinical professor of neurology, University of Montreal, director of the Headache Clinic at the University of Montreal Hospital Centre, and president of Migraine Québec. "I'm proud to be a part of this campaign as it promotes a healthier and more inclusive workplace practice in service to the overall health of patients." For more information on migraine, please visit or About Migraine Canada Migraine Canada is a nationally-registered charity organization dedicated to improving the lives of all Canadians living with migraine and other headache disorders. Our vision is to see that all Canadians living with migraine and headache disorders are diagnosed, treated and supported so their quality of life is optimized. Visit About Migraine Québec Migraine Quebec is a charity organization founded in 2014. Its mission is to enhance the quality of life of people living with migraine throughout Québec. Their vision is to help build a society where people living with migraine can thrive, without limitations or stigmatization. Visit About Pfizer Canada Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. To learn more about Pfizer Canada, visit or you can follow us on LinkedIn, Facebook, X, Instagram or YouTube.
